Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.88 USD | -0.94% |
|
-3.86% | +8.04% |
May. 14 | Transcript : Kiniksa Pharmaceuticals, Ltd. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:40 AM | |
Apr. 23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.04% | 1.35B | |
+18.20% | 125B | |
+13.51% | 108B | |
-7.23% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.23% | 16.37B | |
+1.28% | 13.58B | |
+27.78% | 11.66B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals, Ltd.
- (KNSA) KINIKSA PHARMACEUTICALS Sees Q3 EPS $0.21